These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 30235216)
21. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003. Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277 [TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625 [TBL] [Abstract][Full Text] [Related]
23. Clinical and economic burden of HPV-related cancers in the US veteran population. Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867 [TBL] [Abstract][Full Text] [Related]
24. Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database. St Guily JL; Borget I; Vainchtock A; Rémy V; Takizawa C Head Neck Oncol; 2010 Sep; 2():22. PubMed ID: 20809978 [TBL] [Abstract][Full Text] [Related]
25. HPV in genital cancers (at the exception of cervical cancer) and anal cancers. de Sanjosé S; Bruni L; Alemany L Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637 [TBL] [Abstract][Full Text] [Related]
26. Patterns and trends of HPV-related cancers other than cervix in South Africa from 1994-2013. Chikandiwa A; Pisa PT; Sengayi M; Singh E; Delany-Moretlwe S Cancer Epidemiol; 2019 Feb; 58():121-129. PubMed ID: 30557819 [TBL] [Abstract][Full Text] [Related]
27. The burden and costs of prevention and management of genital disease caused by HPV in women: a population-based registry study in Finland. Salo H; Leino T; Kilpi T; Auranen K; Tiihonen P; Lehtinen M; Vänskä S; Linna M; Nieminen P Int J Cancer; 2013 Sep; 133(6):1459-69. PubMed ID: 23463194 [TBL] [Abstract][Full Text] [Related]
28. The costs of treating vaginal and vulval cancer in England (2009-2015). Stephens S; Chatterjee A; Coles V; Crawford R BMC Public Health; 2020 Apr; 20(1):453. PubMed ID: 32252711 [TBL] [Abstract][Full Text] [Related]
29. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. Hartwig S; Syrjänen S; Dominiak-Felden G; Brotons M; Castellsagué X BMC Cancer; 2012 Jan; 12():30. PubMed ID: 22260541 [TBL] [Abstract][Full Text] [Related]
30. Assessing the burden of HPV-related cancers in Appalachia. Reiter PL; Fisher JL; Hudson AG; Tucker TC; Plascak JJ; Paskett ED Hum Vaccin Immunother; 2013 Jan; 9(1):90-6. PubMed ID: 23143774 [TBL] [Abstract][Full Text] [Related]
31. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Gillison ML; Chaturvedi AK; Lowy DR Cancer; 2008 Nov; 113(10 Suppl):3036-46. PubMed ID: 18980286 [TBL] [Abstract][Full Text] [Related]
32. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan. Insinga RP; Ye X; Singhal PK; Carides GW Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080 [TBL] [Abstract][Full Text] [Related]
33. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT; J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419 [TBL] [Abstract][Full Text] [Related]
34. Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination. Aljunid S; Zafar A; Saperi S; Amrizal M Asian Pac J Cancer Prev; 2010; 11(6):1551-9. PubMed ID: 21338196 [TBL] [Abstract][Full Text] [Related]
35. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark. Olsen J; Jørgensen TR; Kofoed K; Larsen HK BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352 [TBL] [Abstract][Full Text] [Related]
36. Economic impact of human papillomavirus-associated head and neck cancers in the United States. Coughlan D; Frick KD Otolaryngol Clin North Am; 2012 Aug; 45(4):899-917. PubMed ID: 22793859 [TBL] [Abstract][Full Text] [Related]
37. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
38. Cancer attributable to human papillomavirus infection in China: Burden and trends. Lu Y; Li P; Luo G; Liu D; Zou H Cancer; 2020 Aug; 126(16):3719-3732. PubMed ID: 32484937 [TBL] [Abstract][Full Text] [Related]
39. Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998-2007. Nelson EJ; Hughes J; Kulasingam SL Spat Spatiotemporal Epidemiol; 2014 Jun; 9():13-21. PubMed ID: 24889990 [TBL] [Abstract][Full Text] [Related]
40. Trends of human papillomavirus-related head and neck cancers in Korea: national cancer registry data. Shin A; Jung YS; Jung KW; Kim K; Ryu J; Won YJ Laryngoscope; 2013 Nov; 123(11):E30-7. PubMed ID: 23754527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]